In 2025, U.S. federal regulatory activity hits historic lows under Executive Order 14,192, driving deregulation with a one-in, ten-out rule that reduces net regulatory costs. However, broader federal interventions offset some gains.

President Trump's executive order aims to enhance access and affordability for IVF services, potentially reshaping health insurance coverage in the sector.